1/46
Comprehensive vocabulary flashcards covering clinical definitions, pathognomonic signs, diagnostic criteria, autoantibodies, and treatment strategies across rheumatology (RA, SLE, SSc, PM/DM, MCTD, SpA, Gout, and JIA).
Rheumatoid arthritis (RA)
A chronic systemic inflammatory disease primarily involving synovial joints, characterized by symmetric erosive polyarthritis and occasional extra-articular manifestations.
Pannus
An inflamed, proliferating synovial tissue mass driven by autoreactive T cells, B cells, and inflammatory cytokines that invades underlying cartilage, bone, and surrounding periarticular tissues, leading to joint erosion and deformity.
Swan-neck deformity
A characteristic rheumatoid hand deformity defined by hyperextension of the proximal interphalangeal (PIP) joint combined with flexion of the distal interphalangeal (DIP) joint.
Boutonnière deformity
A characteristic rheumatoid hand deformity defined by flexion of the proximal interphalangeal (PIP) joint combined with hyperextension of the distal interphalangeal (DIP) joint.
Z-shaped thumb
A thumb deformity seen in rheumatoid arthritis characterized by flexion of the metacarpophalangeal (MCP) joint accompanied by hyperextension of the interphalangeal (IP) joint.
Felty's syndrome
A severe clinical triad of rheumatoid arthritis (RA), splenomegaly, and neutropenia.
Rheumatoid factor (RF)
An autoantibody present in 85% of RA patients (70% in early RA) that serves as a diagnostic criterion, correlates with bad prognosis, and falls in titer with effective disease control.
Anti-CCP (anti-cyclic citrullinated peptide)
A highly specific autoantibody (98% specificity) for rheumatoid arthritis detectable in early disease and present in 33% of RF-negative RA patients, distinguishing RA from RF-positive mimics like HCV.
ACR 1987 criteria for RA
Diagnostic criteria requiring at least 4 of 7 features, with criteria 1 through 4 present for at least 6 weeks: morning stiffness ≥1 hour, arthritis in ≥3 joint areas, arthritis of hand joints (wrist, MCP, or PIP), symmetric arthritis, subcutaneous nodules, positive RF, and radiographic hand/wrist erosions or periarticular osteopenia.
ACR/EULAR 2010 classification criteria
A classification system requiring confirmed synovitis in at least one joint not explained by another disease, diagnosing RA with a score of ≥6 points across four domains: joint involvement (up to 5 points), serology (RF/ACPA, up to 3 points), acute-phase reactants (ESR/CRP, 1 point), and symptom duration ≥6 weeks (1 point).
Methotrexate (MTX)
The first drug of choice and gold standard conventional synthetic DMARD (csDMARD) for rheumatoid arthritis, noted for its efficacy, rapid action, safety, and ability to retard early radiographic progression.
Systemic lupus erythematosus (SLE)
A chronic inflammatory multisystem connective tissue disease occurring predominantly in females (female:male=9:1) aged 18–45 years, driven by autoantibodies, B-cell hyperactivity, and immune complex deposition.
Butterfly (malar) rash
A fixed erythematous rash over the cheeks and nasal bridge that characteristically spares the nasolabial folds, serving as a classic sign of acute cutaneous lupus.
Libman-Sacks endocarditis
A sterile, non-bacterial verrucous endocarditis affecting cardiac valves in patients with systemic lupus erythematosus.
Lupus nephritis WHO Class IV
Diffuse proliferative glomerulonephritis in systemic lupus erythematosus, presenting clinically with hypertension and variable renal insufficiency.
Anti-dsDNA
An antinuclear antibody specific for systemic lupus erythematosus (present in 60% of cases) whose titers fluctuate and rise during active flares of disease.
Anti-Sm
An antibody against the Smith nuclear antigen that is highly specific for systemic lupus erythematosus.
Anti-histone
An autoantibody highly specific for drug-induced lupus erythematosus.
SLICC 2012 criteria
Classification criteria for SLE requiring either at least 4 criteria (including at least 1 clinical and at least 1 immunologic criterion) OR biopsy-proven lupus nephritis in the presence of positive ANA or anti-dsDNA.
Systemic sclerosis (SSc)
An uncommon connective tissue disease characterized by widespread vascular endothelial damage, abnormal fibroblast activation, excess collagen deposition, and progressive fibrosis of skin and internal organs (GIT, lungs, heart, and kidneys).
Raynaud's phenomenon
Episodic, reversible vasospasm of peripheral digital arterioles triggered by cold exposure, manifested by a classic bilateral sequence of color changes: pallor (ischemia) → cyanosis (deoxygenation) → erythema (reperfusion).
CREST syndrome
A limited cutaneous variant of systemic sclerosis comprising Calcinosis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia.
Anti-Scl70
An autoantibody (anti-topoisomerase I) positive in 20–30% of systemic sclerosis patients, strongly associated with the diffuse cutaneous form and interstitial pulmonary fibrosis.
Anticentromere antibody
An autoantibody positive in 50–90% of limited cutaneous systemic sclerosis (CREST syndrome) patients.
Scleroderma renal crisis
An acute, life-threatening complication of systemic sclerosis presenting with marked accelerated hypertension and renal insufficiency, managed primarily with ACE inhibitors (e.g., captopril).
Polymyositis and dermatomyositis (PM/DM)
Diffuse connective tissue diseases characterized by symmetrical proximal muscle weakness (neck flexors, shoulder, and hip girdles), elevated muscle enzymes (CK, aldolase), an EMG triad, muscle fiber necrosis, and in DM, characteristic skin rashes (heliotrope rash, Gottron's papules).
Mixed connective tissue disease (MCTD)
An overlap syndrome featuring clinical aspects of SLE, systemic sclerosis, polymyositis/dermatomyositis, and occasionally RA, characterized clinically by prominent Raynaud's phenomenon and serologically by high-titer anti-RNP antibodies.
Seronegative spondyloarthropathies (SpA)
A family of chronic inflammatory rheumatologic disorders characterized by involvement of the axial spine, sacroiliac joints, peripheral joints, and entheses, paired with absence of rheumatoid factor (RF) and a strong association with HLA-B27.
Inflammatory back pain (IBP)
Axial spine pain characterized by insidious onset, age at onset <40 years (<45 years for ASAS entry criteria), duration >3 months, morning stiffness >60 minutes, nocturnal waking, and relief with exercise but not with rest.
Enthesitis
Inflammation occurring at the anatomical site where tendons, ligaments, or joint capsules insert into bone, most commonly localized to the Achilles tendon and plantar fascia insertions.
Ankylosing spondylitis (AS)
A prototype seronegative axial spondyloarthropathy (male:female=2:1, onset age 16–45) strongly linked to HLA-B27, characterized by bilateral sacroiliitis, syndesmophyte bridging, bamboo spine, and reduced chest expansion.
Modified New York criteria (1984)
Diagnostic criteria for ankylosing spondylitis requiring radiographic sacroiliitis (grade ≥2 bilaterally or grades 3–4 unilaterally) plus at least one clinical sign: inflammatory back pain, limited sagittal/frontal lumbar spinal mobility, or reduced chest expansion.
Reactive arthritis (ReA)
A sterile synovitis arising after an antecedent extra-articular urogenital (Chlamydia) or gastrointestinal (Salmonella, Shigella, Yersinia, Campylobacter) infection, traditionally presenting with arthritis, urethritis, and conjunctivitis.
Dactylitis
Uniform, diffuse soft-tissue swelling of an entire digit ('sausage finger' or 'sausage toe'), typical of psoriatic arthritis, reactive arthritis, and enteropathic spondyloarthropathy.
Gout
An inflammatory crystal arthropathy resulting from disordered purine metabolism, characterized by hyperuricemia and articular or soft-tissue deposition of monosodium urate (MSU) crystals.
Hyperuricemia
Elevation of serum uric acid levels above the saturation threshold, defined as >7mg/dl in adult men, >6mg/dl in adult women, and >5mg/dl in children.
Podagra
Severe, sudden-onset, acute monoarticular inflammatory arthritis of the first metatarsophalangeal (MTP) joint, representing the classic initial presentation of gout.
Tophi
Firm to hard chalky subcutaneous nodules formed by aggregated monosodium urate crystal deposits, characteristically located around olecranon bursae, finger joints, and the helix of the ear in chronic gout.
Monosodium urate (MSU) crystals
Needle-shaped synovial fluid crystals demonstrating strong negative birefringence under polarized light microscopy, pathognomonic for gout.
Allopurinol
A xanthine oxidase inhibitor used as the first-line urate-lowering therapy (100–800mg/day) titrated to achieve a target serum urate level <6mg/dl (<5mg/dl in severe tophaceous disease).
Pseudogout (CPPD)
An acute inflammatory arthritis caused by shedding of calcium pyrophosphate dihydrate crystals from articular cartilage into the joint space, most commonly involving the knee, wrist, and shoulder.
Chondrocalcinosis
Radiological calcification within articular hyaline or fibrocartilage, serving as an essential radiographic clue for calcium pyrophosphate deposition (CPPD) disease.
Juvenile idiopathic arthritis (JIA)
A diverse family of inflammatory joint diseases characterized by persistent objective arthritis for longer than 6 weeks with onset before 16 years of age, having excluded other causes.
Systemic JIA (sJIA)
A JIA category (5–10% of cases) presenting with arthritis and daily quotidian spiking fevers for at least 2 weeks, associated with an evanescent salmon-pink erythematous rash, lymphadenopathy, hepatosplenomegaly, and serositis.
Oligoarticular JIA
The most common form of JIA (50% of cases), defined by arthritis affecting 1–4 joints during the first 6 months, characterized by a 70% rate of ANA positivity and a high risk of chronic asymptomatic anterior uveitis.
Enthesitis-related arthritis (ERA)
A subtype of JIA characterized by arthritis and enthesitis (or one with features such as sacroiliac tenderness, HLA-B27 positivity, male onset >6 years, or acute symptomatic anterior uveitis), typically affecting the lower extremities.
pGALS
A rapid, validated clinical screening examination assessing paediatric Gait, Arms, Legs, and Spine to detect musculoskeletal disease and joint abnormalities in children.